Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$544K Buy
4,224
+154
+4% +$20.2K 0.15% 62
2025
Q4
$570K Sell
4,070
-781
-16% -$112K 0.16% 60
2025
Q3
$708K Sell
4,851
-26
-0.5% -$3.61K 0.21% 53
2025
Q2
$647K Sell
4,877
-435
-8% -$52.7K 0.2% 56
2025
Q1
$587K Sell
5,312
-34
-0.6% -$4.21K 0.21% 55
2024
Q4
$701K Buy
5,346
+263
+5% +$33.3K 0.24% 52
2024
Q3
$681K Buy
5,083
+1,168
+30% +$156K 0.24% 51
2024
Q2
$546K Sell
3,915
-348
-8% -$47.3K 0.2% 49
2024
Q1
$546K Buy
4,263
+98
+2% +$11.8K 0.22% 42
2023
Q4
$481K Buy
4,165
+71
+2% +$7.09K 0.2% 44
2023
Q3
$359K Buy
4,094
+1,811
+79% +$187K 0.18% 43
2023
Q2
$261K Buy
+2,283
New +$241K 0.13% 42

Other funds holding XYL

Evexia Wealth's XYL Position: Q1 2026 in Review

Evexia Wealth increased its Xylem (XYL) stake by 3.8% in Q1 2026, buying an estimated $20.2K and bringing the position to 4,224 shares worth $544K. The position accounts for 0.15% of the portfolio, ranked #62.

Evexia Wealth first reported a position in XYL in Q2 2023 and has held it in 12 quarters since. The position peaked at $708K in Q3 2025. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Evexia Wealth held 4,224 shares of Xylem worth $544K as of Q1 2026.
  • Evexia Wealth bought 154 Xylem shares in Q1 2026, an estimated $20.2K.
  • Xylem made up 0.15% of Evexia Wealth's portfolio in Q1 2026, its #62 holding.
  • Evexia Wealth first reported a position in Xylem in Q2 2023 and has held it in 12 quarters since.
  • Evexia Wealth's Xylem position peaked at $708K in Q3 2025.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Evexia Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.